Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Constantine Cannon"


3 mentions found


The giant health insurers Cigna and Humana are reportedly considering a merger. While they offer different kinds of health insurance, the deal is likely to face antitrust scrutiny. Still, Cigna and Humana did toy with a deal way back in 2014 before they pursued deals with other partners. Later, to sidestep antitrust scrutiny, health insurers eyed mergers with other pieces of the healthcare system outside of insurance. Cigna and Humana would face a more skeptical Justice DepartmentAny deal between health insurers the size of Cigna and Humana would have to get past the Justice Department's antitrust enforcers.
Persons: Biden, , Justice that's, BofA, David Balto, Cigna, That's, Balto, Barak Richman, there's, Matthew Cantor, Constantine Cannon, divestitures aren't, Molina wouldn't, Cantor Organizations: Humana, Service, Reuters, Bloomberg, Street, Department, Justice, Cigna, UnitedHealth Group, Equity, Federal Trade Commission, Justice Department, Express, CVS Health, Aetna, Kindred, Biden Administration, FTC, Duke University Locations: Cigna, Aetna, Delaware
The Securities and Exchange Commission — which implemented a whistleblower program in 2011 and where Haugen and others have sent documents — has received a historic jump in complaints over the past few years. How remote work sparked a flood of whistleblowersAs the pandemic spread and workers retreated to their makeshift home offices, employees began to reconsider their relationship with work. MacGann, the Uber whistleblower, told Politico that it wasn't until the pandemic that he "had time on his hands" to really ponder his decision to come forward about the ride-hailing company's treatment of workers. Remote work, she explained, helps to remove some of those barriers to whistleblowing. In addition to the record-breaking number of tips, the SEC whistleblowing program awarded $229 million in 103 cases this year.
AbbVie and lawyers for the plaintiffs did not immediately respond to requests for comment. The lawsuit claims the settlements were so-called "pay for delay" deals that violated competition laws in 30 states and resulted in higher prices. The generic companies previously settled with the health plans for a combined $2 million. Allergan previously reached a $750 million settlement of antitrust allegations brought by direct purchasers of Namenda, such as drug distributors. The case is In re Namenda Indirect Purchaser Antitrust Litigation, U.S. District Court, Southern District of New York, No.
Total: 3